NVIDIA Corporation helps Uber Technologies, Inc. (UBER) and Autobrains to pilot Robotaxis in Munich.
Uber (UBER.US) teams up with Autobrains and Nvidia (NVDA.US) to launch the Robotaxi project in Munich, aiming to create a self-driving ride-hailing model compatible with multiple car manufacturers.
Uber Technologies, Inc. (UBER.US) and Israeli autonomous driving technology company Autobrains announced on Monday that they will be collaborating with U.S. chip manufacturer NVIDIA Corporation (NVDA.US) to launch an autonomous taxi project in Munich, Germany, in an effort to scale up the autonomous driving ride-hailing business in Europe.
The three parties plan to integrate Uber Technologies, Inc.'s mobility network with Autobrains' "Intelligent Body AI" driving system, running on NVIDIA Corporation's Drive Hyperion platform, and will first deploy the service in Munich, with further services needing to go through regulatory approval processes before being launched.
The project aims to expand Robotaxi services beyond isolated test points and operate on multiple vehicle platforms and in various city markets through a "cross-OEM" model. Autobrains' system breaks down driving decisions into multiple specialized intelligent bodies that can respond in real time using standard onboard sensors.
Munich has become a key testing ground for autonomous driving in Europe, with Uber Technologies, Inc. previously stating plans to commence autonomous driving tests in the area from 2026 onwards.
Related Articles

XIAO NOODLES (02408) spent HK$1.4016 million to repurchase 33,650 shares on June 1st.

Innovative Medical Management (002173.SZ) plans to repurchase company shares worth 50 million to 100 million yuan.

Sichuan Biokin Pharmaceutical (688506.SH) plans to repurchase shares worth 100 million to 200 million yuan.
XIAO NOODLES (02408) spent HK$1.4016 million to repurchase 33,650 shares on June 1st.

Innovative Medical Management (002173.SZ) plans to repurchase company shares worth 50 million to 100 million yuan.

Sichuan Biokin Pharmaceutical (688506.SH) plans to repurchase shares worth 100 million to 200 million yuan.






